Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Direct Access Partners acquires EFX Prime

Tuesday, September 14, 2010
Direct Access Partners LLC, the institutional agency-only brokerage firm providing multi-asset trade execution and support services, announced that it will acquire EFX Prime Services, a division of First New York Securities, to enhance its rapidly growing Global Prime Services business. The new team complements Direct Access Partners’ Capital Raising Group, and provides hedge fund clients with an integrated capital introduction and capital raising platform – a unique offering among correspondent prime brokers.

The deal integrates the EFX Prime Services team into Direct Access Partners including Brian Stutman joining as Managing Director, Andrew Saunders who will lead the Capital Introduction program and, Geoff Webster who joins the Prime Operations Group.

“The addition of the EFX Prime team adds significant expertise, strong client relationships and a successful Capital Introduction program to our Global Prime effort,” said Direct Access Partners CEO, Ben Chinea. “Working with our proven Capital Raising team, Direct Access Partners is optimally positioned to address the entire spectrum of hedge fund clients – including start-ups, emerging funds and established managers.”

Direct Access Partners Global Prime Services provide a single point of contact for both back-office operations and technology and allows clients to opt for either a single or multi-prime solution with best-of-breed custodians. Direct Access Partners’ clients have access to a comprehensive service offering including multi-asset execution in over 100 global markets, independent research, corporate access, securities lending, capital introduction, capital raising and strategic business consulting.

(press release)

Corporate website

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t